nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A2—Carmustine—malignant glioma	0.372	0.57	CbGbCtD
Toremifene—CYP3A4—Temozolomide—malignant glioma	0.281	0.43	CbGbCtD
Toremifene—Paresis—Temozolomide—malignant glioma	0.01	0.0515	CcSEcCtD
Toremifene—Disorder sight—Temozolomide—malignant glioma	0.00769	0.0395	CcSEcCtD
Toremifene—Deep vein thrombosis—Temozolomide—malignant glioma	0.00602	0.0309	CcSEcCtD
Toremifene—Embolism—Temozolomide—malignant glioma	0.00571	0.0293	CcSEcCtD
Toremifene—Cyst—Carmustine—malignant glioma	0.00567	0.0291	CcSEcCtD
Toremifene—Thrombosis—Carmustine—malignant glioma	0.00535	0.0275	CcSEcCtD
Toremifene—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00495	0.0254	CcSEcCtD
Toremifene—Rigors—Temozolomide—malignant glioma	0.00449	0.023	CcSEcCtD
Toremifene—Coordination abnormal—Carmustine—malignant glioma	0.00386	0.0198	CcSEcCtD
Toremifene—Pulmonary embolism—Carmustine—malignant glioma	0.00379	0.0194	CcSEcCtD
Toremifene—Coordination abnormal—Temozolomide—malignant glioma	0.00373	0.0191	CcSEcCtD
Toremifene—Pulmonary embolism—Temozolomide—malignant glioma	0.00366	0.0188	CcSEcCtD
Toremifene—Dry eye—Temozolomide—malignant glioma	0.00338	0.0173	CcSEcCtD
Toremifene—Abnormal vision—Carmustine—malignant glioma	0.00331	0.017	CcSEcCtD
Toremifene—Abnormal vision—Temozolomide—malignant glioma	0.00319	0.0164	CcSEcCtD
Toremifene—Thrombophlebitis—Carmustine—malignant glioma	0.00318	0.0163	CcSEcCtD
Toremifene—Thrombophlebitis—Temozolomide—malignant glioma	0.00307	0.0158	CcSEcCtD
Toremifene—Hot flush—Temozolomide—malignant glioma	0.00284	0.0146	CcSEcCtD
Toremifene—Menopausal symptoms—Temozolomide—malignant glioma	0.00282	0.0144	CcSEcCtD
Toremifene—Diplopia—Carmustine—malignant glioma	0.00275	0.0141	CcSEcCtD
Toremifene—Benzphetamine—POR—malignant glioma	0.00269	0.232	CrCbGaD
Toremifene—Diplopia—Temozolomide—malignant glioma	0.00266	0.0136	CcSEcCtD
Toremifene—Affect lability—Temozolomide—malignant glioma	0.00262	0.0134	CcSEcCtD
Toremifene—Ataxia—Carmustine—malignant glioma	0.00259	0.0133	CcSEcCtD
Toremifene—Liver function test abnormal—Carmustine—malignant glioma	0.00254	0.013	CcSEcCtD
Toremifene—Mood swings—Temozolomide—malignant glioma	0.00252	0.0129	CcSEcCtD
Toremifene—Ataxia—Temozolomide—malignant glioma	0.0025	0.0128	CcSEcCtD
Toremifene—Breast disorder—Temozolomide—malignant glioma	0.0024	0.0123	CcSEcCtD
Toremifene—Ospemifene—CYP2B6—malignant glioma	0.0023	0.198	CrCbGaD
Toremifene—Weight increased—Temozolomide—malignant glioma	0.00209	0.0107	CcSEcCtD
Toremifene—Neuropathy peripheral—Carmustine—malignant glioma	0.00208	0.0107	CcSEcCtD
Toremifene—Neuropathy peripheral—Temozolomide—malignant glioma	0.00201	0.0103	CcSEcCtD
Toremifene—Hepatobiliary disease—Temozolomide—malignant glioma	0.00194	0.00994	CcSEcCtD
Toremifene—Visual impairment—Carmustine—malignant glioma	0.00183	0.00941	CcSEcCtD
Toremifene—Eye disorder—Carmustine—malignant glioma	0.00178	0.00912	CcSEcCtD
Toremifene—Visual impairment—Temozolomide—malignant glioma	0.00177	0.00909	CcSEcCtD
Toremifene—Eye disorder—Temozolomide—malignant glioma	0.00172	0.00881	CcSEcCtD
Toremifene—Arrhythmia—Carmustine—malignant glioma	0.0017	0.00872	CcSEcCtD
Toremifene—Alopecia—Carmustine—malignant glioma	0.00168	0.00863	CcSEcCtD
Toremifene—Angiopathy—Temozolomide—malignant glioma	0.00167	0.00856	CcSEcCtD
Toremifene—Mental disorder—Carmustine—malignant glioma	0.00167	0.00855	CcSEcCtD
Toremifene—Mediastinal disorder—Temozolomide—malignant glioma	0.00166	0.0085	CcSEcCtD
Toremifene—Malnutrition—Carmustine—malignant glioma	0.00166	0.0085	CcSEcCtD
Toremifene—Chills—Temozolomide—malignant glioma	0.00165	0.00846	CcSEcCtD
Toremifene—Alopecia—Temozolomide—malignant glioma	0.00163	0.00834	CcSEcCtD
Toremifene—Mental disorder—Temozolomide—malignant glioma	0.00161	0.00826	CcSEcCtD
Toremifene—Back pain—Carmustine—malignant glioma	0.0016	0.00822	CcSEcCtD
Toremifene—Malnutrition—Temozolomide—malignant glioma	0.0016	0.00821	CcSEcCtD
Toremifene—Vision blurred—Carmustine—malignant glioma	0.00156	0.00801	CcSEcCtD
Toremifene—Tremor—Carmustine—malignant glioma	0.00155	0.00796	CcSEcCtD
Toremifene—Back pain—Temozolomide—malignant glioma	0.00155	0.00794	CcSEcCtD
Toremifene—Vision blurred—Temozolomide—malignant glioma	0.00151	0.00774	CcSEcCtD
Toremifene—Tremor—Temozolomide—malignant glioma	0.0015	0.00769	CcSEcCtD
Toremifene—Leukopenia—Carmustine—malignant glioma	0.00148	0.00761	CcSEcCtD
Toremifene—Vertigo—Temozolomide—malignant glioma	0.00144	0.00738	CcSEcCtD
Toremifene—Leukopenia—Temozolomide—malignant glioma	0.00143	0.00735	CcSEcCtD
Toremifene—Chest pain—Carmustine—malignant glioma	0.00141	0.00723	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00135	0.00694	CcSEcCtD
Toremifene—Oedema—Carmustine—malignant glioma	0.00135	0.00693	CcSEcCtD
Toremifene—Thrombocytopenia—Carmustine—malignant glioma	0.00132	0.00679	CcSEcCtD
Toremifene—Oedema—Temozolomide—malignant glioma	0.00131	0.0067	CcSEcCtD
Toremifene—Anorexia—Carmustine—malignant glioma	0.00129	0.00661	CcSEcCtD
Toremifene—Nervous system disorder—Temozolomide—malignant glioma	0.00128	0.00657	CcSEcCtD
Toremifene—Thrombocytopenia—Temozolomide—malignant glioma	0.00128	0.00656	CcSEcCtD
Toremifene—Skin disorder—Temozolomide—malignant glioma	0.00127	0.00651	CcSEcCtD
Toremifene—Hyperhidrosis—Temozolomide—malignant glioma	0.00126	0.00648	CcSEcCtD
Toremifene—Anorexia—Temozolomide—malignant glioma	0.00125	0.00639	CcSEcCtD
Toremifene—Insomnia—Carmustine—malignant glioma	0.00122	0.00627	CcSEcCtD
Toremifene—Dyspnoea—Carmustine—malignant glioma	0.00121	0.00618	CcSEcCtD
Toremifene—Insomnia—Temozolomide—malignant glioma	0.00118	0.00606	CcSEcCtD
Toremifene—Decreased appetite—Carmustine—malignant glioma	0.00118	0.00603	CcSEcCtD
Toremifene—Gastrointestinal disorder—Carmustine—malignant glioma	0.00117	0.00599	CcSEcCtD
Toremifene—Dyspnoea—Temozolomide—malignant glioma	0.00116	0.00597	CcSEcCtD
Toremifene—Pain—Carmustine—malignant glioma	0.00116	0.00593	CcSEcCtD
Toremifene—Constipation—Carmustine—malignant glioma	0.00116	0.00593	CcSEcCtD
Toremifene—Decreased appetite—Temozolomide—malignant glioma	0.00114	0.00583	CcSEcCtD
Toremifene—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00113	0.00579	CcSEcCtD
Toremifene—Fatigue—Temozolomide—malignant glioma	0.00113	0.00578	CcSEcCtD
Toremifene—Pain—Temozolomide—malignant glioma	0.00112	0.00573	CcSEcCtD
Toremifene—Constipation—Temozolomide—malignant glioma	0.00112	0.00573	CcSEcCtD
Toremifene—Loperamide—CYP2B6—malignant glioma	0.00104	0.0899	CrCbGaD
Toremifene—Diphenhydramine—CYP2C18—malignant glioma	0.00104	0.0894	CrCbGaD
Toremifene—Asthenia—Carmustine—malignant glioma	0.00097	0.00498	CcSEcCtD
Toremifene—Benzphetamine—CYP2B6—malignant glioma	0.00096	0.0828	CrCbGaD
Toremifene—Asthenia—Temozolomide—malignant glioma	0.000938	0.00481	CcSEcCtD
Toremifene—Pruritus—Temozolomide—malignant glioma	0.000924	0.00474	CcSEcCtD
Toremifene—Dizziness—Carmustine—malignant glioma	0.000894	0.00459	CcSEcCtD
Toremifene—Dizziness—Temozolomide—malignant glioma	0.000864	0.00443	CcSEcCtD
Toremifene—Vomiting—Carmustine—malignant glioma	0.00086	0.00441	CcSEcCtD
Toremifene—Rash—Carmustine—malignant glioma	0.000853	0.00437	CcSEcCtD
Toremifene—Dermatitis—Carmustine—malignant glioma	0.000852	0.00437	CcSEcCtD
Toremifene—Headache—Carmustine—malignant glioma	0.000847	0.00434	CcSEcCtD
Toremifene—Vomiting—Temozolomide—malignant glioma	0.000831	0.00426	CcSEcCtD
Toremifene—Rash—Temozolomide—malignant glioma	0.000824	0.00423	CcSEcCtD
Toremifene—Dermatitis—Temozolomide—malignant glioma	0.000823	0.00422	CcSEcCtD
Toremifene—Headache—Temozolomide—malignant glioma	0.000819	0.0042	CcSEcCtD
Toremifene—Benzphetamine—SLC6A3—malignant glioma	0.000818	0.0705	CrCbGaD
Toremifene—Nausea—Carmustine—malignant glioma	0.000803	0.00412	CcSEcCtD
Toremifene—Nausea—Temozolomide—malignant glioma	0.000776	0.00398	CcSEcCtD
Toremifene—Diphenhydramine—CYP2B6—malignant glioma	0.000769	0.0663	CrCbGaD
Toremifene—Tamoxifen—CYP2B6—malignant glioma	0.000749	0.0646	CrCbGaD
Toremifene—Orphenadrine—CYP2B6—malignant glioma	0.000728	0.0627	CrCbGaD
Toremifene—Diphenhydramine—PTGS1—malignant glioma	0.000506	0.0436	CrCbGaD
Toremifene—ESR1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000117	0.000835	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000116	0.000829	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	0.000116	0.000829	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000116	0.000827	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000114	0.000811	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—EGFR—malignant glioma	0.000113	0.000807	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000112	0.000801	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—DNMT3B—malignant glioma	0.000109	0.000781	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000107	0.000766	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—COX8A—malignant glioma	0.000107	0.000766	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—KRAS—malignant glioma	0.000107	0.000762	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000107	0.000761	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HIST1H3B—malignant glioma	0.000106	0.000758	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000105	0.000747	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MDK—malignant glioma	0.000103	0.000732	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PIK3CA—malignant glioma	9.81e-05	0.0007	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DTX1—malignant glioma	9.79e-05	0.000699	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	9.63e-05	0.000687	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—malignant glioma	9.61e-05	0.000686	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	9.59e-05	0.000684	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	9.56e-05	0.000682	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—malignant glioma	9.54e-05	0.000681	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	9.42e-05	0.000672	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	9.26e-05	0.000661	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—RTEL1—malignant glioma	9.19e-05	0.000656	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	9.15e-05	0.000653	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ASMT—malignant glioma	9.12e-05	0.000651	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTP1—malignant glioma	9.09e-05	0.000649	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	8.97e-05	0.00064	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	8.96e-05	0.00064	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	8.91e-05	0.000636	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	8.89e-05	0.000635	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—NOTCH1—malignant glioma	8.89e-05	0.000634	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—BCAN—malignant glioma	8.57e-05	0.000612	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—COX8A—malignant glioma	8.57e-05	0.000611	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.51e-05	0.000607	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—PPARG—malignant glioma	8.39e-05	0.000599	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	8.26e-05	0.00059	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.23e-05	0.000588	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—H3F3A—malignant glioma	8.21e-05	0.000586	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	8.17e-05	0.000583	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	8.06e-05	0.000575	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—AKT1—malignant glioma	8.01e-05	0.000572	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	7.91e-05	0.000564	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	7.79e-05	0.000556	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SUFU—malignant glioma	7.78e-05	0.000555	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH3—malignant glioma	7.71e-05	0.00055	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HEY2—malignant glioma	7.68e-05	0.000548	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GFAP—malignant glioma	7.5e-05	0.000535	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	7.4e-05	0.000528	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	7.29e-05	0.00052	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ASMT—malignant glioma	7.28e-05	0.00052	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	7.28e-05	0.00052	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	7.26e-05	0.000519	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SPHK1—malignant glioma	7.26e-05	0.000518	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	7.19e-05	0.000513	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HEY1—malignant glioma	7.11e-05	0.000508	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCR4—malignant glioma	7.11e-05	0.000508	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	7.03e-05	0.000502	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH2—malignant glioma	6.91e-05	0.000493	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—IDH2—malignant glioma	6.91e-05	0.000493	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIST1H3B—malignant glioma	6.91e-05	0.000493	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BCAN—malignant glioma	6.85e-05	0.000489	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—COX8A—malignant glioma	6.84e-05	0.000488	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.69e-05	0.000477	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.68e-05	0.000476	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	6.52e-05	0.000466	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.52e-05	0.000465	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2B6—malignant glioma	6.5e-05	0.000464	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.36e-05	0.000454	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JAG2—malignant glioma	6.31e-05	0.00045	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	6.13e-05	0.000437	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.11e-05	0.000436	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—IDH1—malignant glioma	5.94e-05	0.000424	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—CDKN2B—malignant glioma	5.94e-05	0.000424	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ASMT—malignant glioma	5.81e-05	0.000415	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SPHK1—malignant glioma	5.75e-05	0.00041	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.68e-05	0.000406	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NCOR1—malignant glioma	5.63e-05	0.000402	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2C18—malignant glioma	5.63e-05	0.000402	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.54e-05	0.000395	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—IDH2—malignant glioma	5.52e-05	0.000394	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BCAN—malignant glioma	5.47e-05	0.00039	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—H3F3A—malignant glioma	5.34e-05	0.000381	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.31e-05	0.000379	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCR3—malignant glioma	5.29e-05	0.000377	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—COX8A—malignant glioma	5.28e-05	0.000377	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2B6—malignant glioma	5.19e-05	0.00037	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NTRK2—malignant glioma	5.14e-05	0.000367	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—YWHAE—malignant glioma	5.14e-05	0.000367	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FLT1—malignant glioma	5.12e-05	0.000365	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DUSP6—malignant glioma	5.1e-05	0.000364	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	5.09e-05	0.000364	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JAG1—malignant glioma	5.03e-05	0.000359	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH3—malignant glioma	5.01e-05	0.000358	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.98e-05	0.000356	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FBXW7—malignant glioma	4.93e-05	0.000352	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.84e-05	0.000345	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BDKRB2—malignant glioma	4.83e-05	0.000345	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—malignant glioma	4.78e-05	0.000341	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—IDH1—malignant glioma	4.75e-05	0.000339	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.74e-05	0.000339	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.71e-05	0.000336	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.67e-05	0.000333	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SPHK1—malignant glioma	4.59e-05	0.000328	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTT1—malignant glioma	4.56e-05	0.000325	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2C18—malignant glioma	4.5e-05	0.000321	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH2—malignant glioma	4.49e-05	0.000321	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ASMT—malignant glioma	4.49e-05	0.00032	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—IDH2—malignant glioma	4.41e-05	0.000315	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KNG1—malignant glioma	4.4e-05	0.000314	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.32e-05	0.000309	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH1—malignant glioma	4.28e-05	0.000305	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS1—malignant glioma	4.27e-05	0.000305	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.25e-05	0.000304	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BCAN—malignant glioma	4.22e-05	0.000301	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NTRK1—malignant glioma	4.19e-05	0.000299	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	4.18e-05	0.000299	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.16e-05	0.000297	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2B6—malignant glioma	4.14e-05	0.000296	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—malignant glioma	4.04e-05	0.000288	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—BCHE—malignant glioma	3.97e-05	0.000283	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC5A5—malignant glioma	3.92e-05	0.00028	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP3—malignant glioma	3.9e-05	0.000278	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN2B—malignant glioma	3.86e-05	0.000276	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—IDH1—malignant glioma	3.79e-05	0.00027	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTK2—malignant glioma	3.75e-05	0.000268	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.71e-05	0.000265	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HES1—malignant glioma	3.68e-05	0.000263	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.67e-05	0.000262	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SPHK1—malignant glioma	3.67e-05	0.000262	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NCOR1—malignant glioma	3.66e-05	0.000261	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTT1—malignant glioma	3.64e-05	0.00026	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.59e-05	0.000256	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.53e-05	0.000252	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDGFRA—malignant glioma	3.51e-05	0.00025	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS1—malignant glioma	3.41e-05	0.000243	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SPP1—malignant glioma	3.41e-05	0.000243	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—IDH2—malignant glioma	3.4e-05	0.000243	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.39e-05	0.000242	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TERT—malignant glioma	3.23e-05	0.00023	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.2e-05	0.000229	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.2e-05	0.000228	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BCHE—malignant glioma	3.17e-05	0.000226	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTP1—malignant glioma	3.16e-05	0.000225	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDGFB—malignant glioma	3.15e-05	0.000225	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGFR1—malignant glioma	3.14e-05	0.000224	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC5A5—malignant glioma	3.13e-05	0.000224	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIF1A—malignant glioma	3.09e-05	0.00022	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.09e-05	0.00022	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAT—malignant glioma	3.07e-05	0.000219	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CAV1—malignant glioma	2.99e-05	0.000213	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.98e-05	0.000213	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KDR—malignant glioma	2.95e-05	0.000211	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—IDH1—malignant glioma	2.92e-05	0.000209	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTT1—malignant glioma	2.91e-05	0.000207	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NCOR1—malignant glioma	2.9e-05	0.000207	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.88e-05	0.000206	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FN1—malignant glioma	2.84e-05	0.000203	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—F2—malignant glioma	2.84e-05	0.000203	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SPHK1—malignant glioma	2.83e-05	0.000202	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BAD—malignant glioma	2.81e-05	0.0002	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH1—malignant glioma	2.78e-05	0.000199	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.77e-05	0.000198	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CD80—malignant glioma	2.73e-05	0.000195	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS1—malignant glioma	2.72e-05	0.000194	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APC—malignant glioma	2.72e-05	0.000194	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—malignant glioma	2.72e-05	0.000194	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.71e-05	0.000194	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGF—malignant glioma	2.69e-05	0.000192	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTPN11—malignant glioma	2.67e-05	0.000191	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BRAF—malignant glioma	2.56e-05	0.000183	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BCHE—malignant glioma	2.53e-05	0.000181	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTP1—malignant glioma	2.52e-05	0.00018	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.5e-05	0.000178	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT2—malignant glioma	2.49e-05	0.000178	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAT—malignant glioma	2.45e-05	0.000175	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CD—malignant glioma	2.39e-05	0.000171	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAV1—malignant glioma	2.37e-05	0.000169	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.36e-05	0.000169	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.34e-05	0.000167	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NCOR1—malignant glioma	2.32e-05	0.000165	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—malignant glioma	2.3e-05	0.000164	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGF2—malignant glioma	2.29e-05	0.000163	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.26e-05	0.000161	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTT1—malignant glioma	2.24e-05	0.00016	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—malignant glioma	2.16e-05	0.000154	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MDM2—malignant glioma	2.14e-05	0.000153	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RAF1—malignant glioma	2.13e-05	0.000152	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB2—malignant glioma	2.11e-05	0.000151	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS1—malignant glioma	2.1e-05	0.00015	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CB—malignant glioma	2.08e-05	0.000149	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—malignant glioma	2.08e-05	0.000148	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.04e-05	0.000146	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTP1—malignant glioma	2.01e-05	0.000144	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL8—malignant glioma	2e-05	0.000143	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAT—malignant glioma	1.96e-05	0.00014	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BCHE—malignant glioma	1.95e-05	0.000139	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.93e-05	0.000138	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—malignant glioma	1.92e-05	0.000137	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—malignant glioma	1.91e-05	0.000137	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.89e-05	0.000135	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAV1—malignant glioma	1.89e-05	0.000135	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOR1—malignant glioma	1.85e-05	0.000132	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—malignant glioma	1.81e-05	0.000129	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTEN—malignant glioma	1.8e-05	0.000129	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—malignant glioma	1.72e-05	0.000123	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—malignant glioma	1.66e-05	0.000119	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.65e-05	0.000118	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—malignant glioma	1.64e-05	0.000117	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—malignant glioma	1.63e-05	0.000116	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—malignant glioma	1.61e-05	0.000115	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—malignant glioma	1.6e-05	0.000114	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTP1—malignant glioma	1.55e-05	0.000111	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CD—malignant glioma	1.51e-05	0.000108	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAT—malignant glioma	1.51e-05	0.000108	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAV1—malignant glioma	1.51e-05	0.000108	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—malignant glioma	1.5e-05	0.000107	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—malignant glioma	1.46e-05	0.000105	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.44e-05	0.000103	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOR1—malignant glioma	1.43e-05	0.000102	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTEN—malignant glioma	1.43e-05	0.000102	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—malignant glioma	1.38e-05	9.87e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.37e-05	9.81e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—malignant glioma	1.33e-05	9.47e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CB—malignant glioma	1.32e-05	9.41e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—malignant glioma	1.31e-05	9.33e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—malignant glioma	1.27e-05	9.07e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—malignant glioma	1.23e-05	8.77e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.21e-05	8.62e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAV1—malignant glioma	1.16e-05	8.31e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTEN—malignant glioma	1.14e-05	8.14e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.06e-05	7.57e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.05e-05	7.52e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—malignant glioma	1.04e-05	7.45e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—malignant glioma	1.04e-05	7.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—malignant glioma	1.02e-05	7.31e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—malignant glioma	1.01e-05	7.19e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CD—malignant glioma	9.32e-06	6.65e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTEN—malignant glioma	9.1e-06	6.49e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—malignant glioma	8.22e-06	5.87e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.13e-06	5.8e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—malignant glioma	8.05e-06	5.75e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—malignant glioma	8.04e-06	5.74e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTEN—malignant glioma	7.02e-06	5.01e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—malignant glioma	6.57e-06	4.69e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—malignant glioma	6.42e-06	4.58e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—malignant glioma	5.24e-06	3.74e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.95e-06	3.54e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—malignant glioma	4.05e-06	2.89e-05	CbGpPWpGaD
